Advertisement

PharmacoEconomics & Outcomes News

, Volume 820, Issue 1, pp 4–4 | Cite as

Alirocumab not cost effective after recent first MI

Clinical study
  • 5 Downloads

References

  1. 1.
    Kazi DS, et al. Cost-Effectiveness of Alirocumab: A Just-in-Time Analysis Based on the ODYSSEY Outcomes Trial. Annals of Internal Medicine : Jan 2019. Available from: URL: http://doi.org/10.7326/M18-1776Google Scholar
  2. 2.
    Hlatky MA. A Pound of Prevention? Assessing the Value of New Cholesterol-Lowering Drugs. Annals of Internal Medicine : Jan 2019. Available from: URL: http://dx.doi.org/10.7326/M18-3632Google Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Personalised recommendations